Abstract: A process prepares a rapidly disintegrating tablet with a disintegration time of at most 15 minutes for the peroral administration of a dry extract of the leaves of Ginkgo biloba, and with a total weight of the tablet of between 150 mg and 300 mg per 100 mg of ginkgo extract contained. Rapidly disintegrating tablets containing dry extract of the leaves of Ginkgo biloba can be prepared, which, due to their smaller dimensions, are easier to take than the tablets used hitherto. In a preferred form, the tablets do not contain lactose and are therefore also well tolerated.

Abstract: The present invention relates to a combination of valerian root extract and lavender oil treating of sleep disorders, as well as to a combination of preparation comprising valerian root extract and lavender oil.

Abstract: The present invention relates to an improved multistep method for the production of an extract of Ginkgo biloba leaves for use as a drug.

Abstract: The invention relates to a plant extract combination of ginkgo and ginseng which is effective especially in a (synergistic) over-additive manner and optionally comprises whitethorn extract. Ginseng is used in the form of an ethanol/ethanol/water extract while ginkgo is used in the form of an acetone/acetone-water extract, for example, and the active extracts are prepared at specific quantitative ratios, particularly <1.1:1, thus unexpectedly boosting the prevention or also the treatment of a decline in the mental capacity related to age or also other disorders.

Abstract: The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4?-O-methyl pyridoxine and/or biflavones, wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on the resin. The invention further relates to an extract from ginkgo biloba having a reduced content of 4?-O-methyl pyridoxine and/or biflavones, which is obtainable by the method according to the present invention, as well as to its use.

Abstract: The present invention relates to the use of an extract made of leaves of Ginkgo biloba for the production of a preparation, or an extract made of leaves of Ginkgo biloba as an agent for the treatment and prophylaxis of the dementia syndrome, the early stages and pre-stages thereof, wherein 180 to 300 mg of Ginkgo extract is administered once a day.

Abstract: The invention relates to production methods for obtaining dry extracts from Pelargonium sidoides and/or Pelargonium reniforme, extracts which may be obtained according to said method, and pharmaceutical products comprising such extracts.

Abstract: The present invention relates to extracts from the bark of corynanthe species, in particular corynanthe pachyceras as well as to their use for the therapy and prophylaxis of diseases of the lower urinary tract, sexual disorders, lipid metabolism disorders, cardiovascular diseases and acute and chronic pain conditions. The present invention further relates to medicaments, dietetic food products and pharmaceutical preparations containing these extracts.

Abstract: The invention relates to extracts from Sophora species, to a method for producing the same and to their use in the prophylaxis and therapy of pathological conditions that are caused by estrogen deficiency or by other hormonal dysregulations.

Abstract: The present invention relates to the use of trisubstituted benzopyranones for the treatment or propylaxis of pathological conditions associated with oxidative stress and/or inflammatory reactions as well as to novel trisubstituted benzopyranones and the physiologically acceptable salts thereof. The present invention further relates to plant extracts, medicaments, dietetic food products and pharmaceutical preparations containing these compounds.

Abstract: The invention relates to an improved and stable (i.e. color-stable and, optionally, stable with regard to its hyperforin content) extract from the overground parts of Hypericum perforatum L., to a method for the preparation thereof, and to pharmaceutical preparations and topical medicaments that contain this extract; in particular, gels for treating skin and mucous membrane irritations and disorders such as acne, atopic dermatitis, neuro-dermatitis, psoriasis, stomatitis, herpes zoster, herpes labialis (lip herpes), warts, varicella (chicken-pox), sores, burns and other bacterial and viral skin and mucous membrane infections and skin disorders that are accompanied by cell proliferation and inflammation.

Abstract: A holder (6), which is suitable in particular for luminaires which do not provide any direct manual access to the capped lighting means, has a slide by means of which the lamp cap and/or the contact pins thereof can be pushed out of the holder or at least released from the holder. In the case of a preferred embodiment, the holder housing (8) is designed in two parts, the housing part (9) being designed as the slide.

Abstract: A lamp holder is provided comprising a housing, a contact pin retainer arranged within the housing, a rotary member rotatably mounted in the housing and a fastener for fastening the rotary member to the housing. The contact pin retainer is adapted to receive a lamp contact pin. The rotary member comprises an insertion slot, a front shield, and a slotted pivot section extending away from the front shield and into the housing The fastener includes a retaining pin fixed to the housing and penetrates a bearing opening provided in an end section of the slotted pivot section.

Abstract: Described are salts of hyperforin and adhyperforin of formula I [A−]m[B]p+  (I) wherein m is an integer from 1 to 3, p is equal to m and gives the total number of positive charges of the residue [B], [A−] is an anion of formula II with n=0 or 1 and [B]p+ is an ion of an alkali metal or an ammonium ion of a salt-forming nitrogen base of formula III wherein R1 through R4 have a variety of meanings including hydrogen, alkyl, cycloalkyl and similar groups which in turn may be substituted with one or more substituents. The salts serve inter alia for enriching or purifying hyperforin and adhyperforin from St. John's Wort extracts. Pharmaceutical preparations containing the salts are used for treating Alzheimer's Disease.

Abstract: The invention provides improved pharmaceutical preparations comprising peppermint oil and caraway oil for the treatment of dyspeptic complaints and cramps in the gastrointestinal region. In particularly preferred embodiments, preparations of the invention comprise high dosages of peppermint oil and caraway oil in a delayed-release form which also preferably consists of an enteric-coated soft gelatin capsule. Related methods also are disclosed.

Abstract: The invention relates to effervescent compositions containing a dry extract of ginkgo biloba and an effervescent mixture. By dissolving the mixture in water a virtually clear and almost neutral solution is produced which is stable during the period of use.

Abstract: Disclosed is an improved extract of Hypericum perforatum L. (St. John's wort) containing Hyperforin, in which the Hyperforin is stabilized against decomposition or degradation by means of a stabilizer.

Abstract: The invention relates to extracts from ginkgo biloba leaves with a reduced 4′-O-methyl pyridoxine and biflavones content, to a method for the production thereof and to medicaments containing said extracts.

Abstract: The invention relates to the use of hyperforin and hyperforin-containing extracts of Hypericum perforatum L. (St. John's wort) in the treatment and prophylaxis of dementia diseases, including Alzheimer's disease, as well as the use of hyperforin and hyperforin-containing extracts for the preparation of a medicament for the treatment and prophylaxis of such dementia diseases.

Abstract: The invention relates to a novel 2H-1-pyran-2-ones of general formula (I), wherein R1 represents an alkyl radical with 2-5 C atoms, a cycloakyl radical with 4-6 C atoms, a cycloalkyl radical with 4-8 C atoms or an alkoxy alkyl radical with a total of 3-5 C atoms and R2 represents a 2-(3, 4-methylene dioxyphenyl) radical or a 2-phenyl ethenyl radical substituted with R3, R4 and R5 in positions 3, 4 and 5, whereby independently from each other R3 and R5 represent methoxy or ethoxy and R4 is a straight chain or branched alkoxy radical with 1-5 C atoms, an alkenyl radical with 3-5 C atoms, a cycloalkoxy radical with 4-6 C atoms, a cycloalkyl radical with 4-8 C atoms or an alkoxy alkoxy radical with a total of 3-5 C atoms. The invention also relates to a method for producing said compunds in addition to novel untermediate products and to a method for the production thereof.